Healthpeak (NYSE: DOC) CDO Scott Bohn sells 10,989 shares

Rhea-AI Filing Summary

HEALTHPEAK PROPERTIES, INC. executive Scott R. Bohn, the company’s CDO and Head of Lab, sold 10,989 shares of Common Stock in an open-market transaction. The weighted average sale price was $19.4504 per share, with individual trades between $19.4250 and $19.4950. After this sale, he directly holds 7,636 shares.

Insider Trade Summary

Net Seller: 10,989 shares ($213,740)

Net Sell 1 txn

Insider Bohn Scott R

Role CDO and Head of Lab

Sold 10,989 shs ($214K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,989	$19.4504	$214K

Holdings After Transaction: Common Stock — 7,636 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 10,989 shares Weighted average sale price: $19.4504 per share Shares owned after sale: 7,636 shares +1 more

4 metrics

Shares sold 10,989 shares Open-market sale of Common Stock

Weighted average sale price $19.4504 per share Open-market transactions on 2026-05-12

Shares owned after sale 7,636 shares Direct ownership following the transaction

Sale price range $19.4250–$19.4950 per share Range of prices across multiple trades

Key Terms

open-market sale, weighted average sales price, Common Stock

3 terms

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sales price financial

"The reported price is a weighted average sales price."

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bohn Scott R

(Last) (First) (Middle)

4600 SOUTH SYRACUSE STREET

SUITE 500

(Street)

DENVER COLORADO 80237

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CDO and Head of Lab

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/12/2026		S		10,989(1)	D	$19.4504	7,636	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price is a weighted average sales price. These shares were sold in multiple transactions at sale prices ranging from $19.4250 to $19.4950. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein

Remarks:

	Carol Samaan, SVP, Legal (Attorney-In-Fact)	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HEALTHPEAK PROPERTIES (DOC) report for Scott R. Bohn?

HEALTHPEAK PROPERTIES reported that CDO and Head of Lab Scott R. Bohn sold 10,989 shares of Common Stock in an open-market transaction. This Form 4 filing records the specific trade details and his updated share ownership position.

At what price did Scott R. Bohn sell HEALTHPEAK PROPERTIES (DOC) shares?

Scott R. Bohn’s sale had a weighted average price of $19.4504 per share. A footnote notes multiple individual trades, with sale prices ranging from $19.4250 to $19.4950 across the reported transactions.

How many HEALTHPEAK PROPERTIES (DOC) shares does Scott R. Bohn own after the sale?

Following the reported open-market sale, Scott R. Bohn directly owns 7,636 shares of HEALTHPEAK PROPERTIES Common Stock. This post-transaction balance is disclosed in the Form 4 as his direct ownership position.

What role does Scott R. Bohn hold at HEALTHPEAK PROPERTIES (DOC)?

Scott R. Bohn serves as Chief Development Officer (CDO) and Head of Lab at HEALTHPEAK PROPERTIES. His corporate officer status is disclosed in the Form 4, which records his recent Common Stock sale.

Was Scott R. Bohn’s HEALTHPEAK PROPERTIES (DOC) share sale a single trade or multiple trades?

The filing states the reported price is a weighted average, meaning shares were sold in multiple transactions. Individual sale prices ranged from $19.4250 to $19.4950, and detailed breakdowns are available upon request as noted in the footnote.